May 07, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine ... Company's 24-valent PCV candidate, in healthy infants. In this study, VAX-24 was well-tolerated and ...

Calabrese also said that the 15-valent (PCV15), 20-valent (PCV20), and 21-valent (PCV21) pneumococcal conjugate vaccines are indicated for all PCV-naïve adults aged 50 years and older and for ...

The blue-chip Dow Jones Industrial Average increased by 0.7% READ ALSO: 11 Best Stocks Under $15 to Buy According ... promising VAX-31 pneumococcal conjugate vaccine (PCV) data in adults last ...

Which serotypes you’re protected against depends on which vaccine you receive. Prevnar 13 (PCV 13) protects against 13 serotypes, Vaxneuvance (PCV15) protects against 15, while Prevnar 20 (PCV20 ...

Ethiopia provides the following basic: one dose of Bacillus Calmette–Guerin (BCG) and oral polio vaccine (OPV) given at birth; three doses each of each pentavalent, OPV, and pneumococcal conjugate ...

BCG is typically given at birth, while the pentavalent, PCV and OPV vaccines are administered in three doses over four months starting at six weeks of age. MMR is first given when the child ...

“We continue to make meaningful progress across our pneumococcal conjugate vaccine (PCV) candidates, with each milestone bringing us closer to potentially delivering the broadest-spectrum PCVs ...